AbhishekMangaonkarMD

Hematology • Rochester, MN

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology, Sickle Cell & Other Anemias

Assistant Professor and Senior Associate Consultant, Mayo Clinic

Join to view full profile

Dr. Mangaonkar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mangaonkar's full profile

Already have an account?

Office
200 1st Street SW
Rochester, MN 55905

Summary

I am a hematology/oncology fellow at the Mayo Clinic.

Education & Training

Mayo Clinic College of Medicine and Science (Phoenix)Fellowship, Hematology and Medical Oncology, 2016 - 2019
Medical College of GeorgiaResidency, Internal Medicine, 2013 - 2016
Grant Medical CollegeClass of 2012

Certifications & Licensure

MN State Medical License 2016 - 2025
MA State Medical License 2020 - 2020
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
National Board of Physicians and Surgeons Hematology
National Board of Physicians and Surgeons Internal Medicine
National Board of Physicians and Surgeons Medical Oncology

Clinical Trials

Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis or Unclassifiable With Ring Sideroblasts Start of enrollment: 2023 Feb 20
TERMINATED
PHASE2

Publications & Presentations

PubMed

Factors associated with survival following allogeneic transplantation for myeloid neoplasms harboring TP53 mutations.
Anmol Baranwal, Kimberly Langer, Vedavyas Gannamani, Danielle Rud, Alia Cibich
Blood Advances. 2025-03-14
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations.
Mithun Vinod Shah, Kevin Hung MBBS FRACP FRCPA, Anmol Baranwal, Monika M Kutyna, Aref Al-Kali
Blood Advances. 2025-03-14
Multihit TP53 Mutations in Myeloproliferative Neoplasms and Acute Myeloid Leukemia: Comparative Analysis of Survival and Risk Factors in 142 Informative Cases.
Saubia Fathima, Maymona Abdelmagid, Ali Alsugair, Kebede H Begna, Aref Al-Kali
American Journal of Hematology. 2025-03-13

Journal Articles

Prognostic Impact of ASXL1 Mutations in Patients with Myelodysplastic Syndromes and Multilineage Dysplasia with or Without Ring Sideroblasts
Abhishek A Mangaonkar, Kebede H Begna, Leukemia Research

Authored Content

Prognostic Impact of ASXL1 Mutations in Patients with Myelodysplastic Syndromes and Multilineage Dysplasia with or Without Ring SideroblastsJuly 2018